- CEO
- Mit Tarun Bharmbhatt
- Sector
- Producer manufacturing
- Industry
- Building products
- Address
- Mumbai India
- IPO Date
- Dec 24, 2015
- Business
- Tavexia Lifecare Limited is an India-based company engaged in the manufacturing, trading, marketing, and distribution of lifestyle wellness products, home fragrance appliances, personal healthcare equipment, and decorative lighting solutions. The company offers a diverse portfolio of consumer wellness and ambient lifestyle products, which includes electric, wooden, and ceramic Kapoor Dani (camphor burners); traditional Bakhoor Dani incense burners; ultrasonic and timer-equipped aroma diffusers; pure essential oils, camphor tablets, and fragrance refills; personal healthcare appliances, such as facial steamers, vaporizers, and steam inhalers; and decorative ambient lighting solutions, including LED aroma lamps, multi-functional table lamps, and customized wooden burners with artistic motifs marketed under brand names such as Brilliance with Time and Time Therapy. The company caters to individual consumers, residential spaces, and commercial establishments across India through a multi-channel sales and distribution infrastructure comprising major online e-commerce platforms, third-party marketplaces, regional distributors, and retail networks. Originally incorporated on August 14, 1980, the company is headquartered in Mumbai, Maharashtra, India, and its equity shares are listed on the BSE. In recent periods, the company has undertaken a significant strategic reorganization, transitioning from its legacy commercial trading and financial dealing operations to concentrate exclusively on the lifestyle, wellness, and lifecare sectors. In connection with this strategic refocusing, the company changed its name from Mayukh Dealtrade Limited to Sattva Sukun Lifecare Limited in August 2024, and subsequently rebranded to Tavexia Lifecare Limited in August 2026 following requisite regulatory approvals from the Ministry of Corporate Affairs and stock exchange authorities. Recent operational advancements encompass the rollout of automated and smart-timer diffuser collections, the expansion of direct-to-consumer digital channels, promoter equity reallocations, and strategic evaluations of expansion opportunities and acquisitions within the broader pharmaceutical and consumer healthcare markets.